DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/dnp284/enterococcus) has announced the addition of the "Enterococcus Faecium Infections - Pipeline Review, H1 2015" report to their offering.
This report provides comprehensive information on the therapeutic development for Enterococcus Faecium Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Enterococcus Faecium Infections and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Companies Involved in Therapeutics Development
- Alchemia Limited
- Alvogen, Inc.
- Aphios Corporation
- Cellceutix Corporation
- ConjuGon, Inc.
- ContraFect Corporation
- Enanta Pharmaceuticals, Inc.
- Helix BioMedix, Inc.
- LegoChem Biosciences, Inc
- Lytix Biopharma AS
- Melinta Therapeutics, Inc
- MGB Biopharma Limited
- Microbiotix, Inc.
- MicuRx Pharmaceuticals, Inc.
- Nabriva Therapeutics AG
- NovaBay Pharmaceuticals, Inc.
- Novan, Inc.
- NovoBiotic Pharmaceuticals, LLC
- Omnia Molecular Ltd.
- Oragenics, Inc.
- Sealife PHARMA GMBH
- Sentinella Pharmaceuticals, Inc.
- Sumitomo Dainippon Pharma Co., Ltd.
- TAXIS Pharmaceuticals, Inc.
- Wockhardt Limited
Drug Profiles
- auriclosene
- brilacidin tetrahydrochloride
- CF-304
- chrysophaentin
- closthioamide
- EDP-788
- Epimerox
- GP-505
- HB-1345
- HT-01
- HT-02
- IBN-1
- LCB-010371
- LCB-010699
- lefamulin
- LTX-109
- Marinus
- MBX-1162
- MGBBP-3
- MRX-I
- MU-1140
- NAI-107
- NAI-603
- NVN-1000
- NVN-4428
- RX-05
- RXP-873
- SLP-0904
- SLP-0905
- SM-295291
- SM-369926
For more information visit http://www.researchandmarkets.com/research/dnp284/enterococcus
